Browse 1,565 thyroid cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Most thyroid cancers grow slowly and have some of the best outcomes of any cancer, which is why some small ones can now be safely monitored instead of removed right away. A small share behave very differently: cancers that stop responding to radioactive iodine, inherited medullary thyroid cancer, and the rare but aggressive anaplastic type. Targeted medicines matched to specific gene changes have opened new options for these groups.
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
for
Malignant Neoplasm
Location: Sherbrooke, New York NY, Hackensack NJ, Montreal,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06979596
Phase 2, Recruiting
Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer
for
NSCLC, Locally Advanced
Location: The Bronx NY
Sponsor: Montefiore Medical Center
Sex: All
Age: 18+
Code: NCT06865339
Phase 2, Recruiting
[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
Clinical and Genetic Studies of Li-Fraumeni Syndrome
for
Li-Fraumeni Syndrome, Neoplasms, Tp53 Mutations
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0+
Code: NCT01443468
Recruiting
XL092 and Cemiplimab in BRAF WT Thyroid Cancer
for
Anaplastic Thyroid Cancer, Thyroid Cancer,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT06902376
Phase 1, Recruiting
Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.